Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in Journal of Clinical Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
JO
Journal of Clinical Oncology is an ASCO journal covering clinical oncology research and publishing article types including original reports, clinical trial updates, special articles, correspondence, rapid communications, and ASCO special articles.
Looking to publish in Journal of Clinical Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
Subject
Oncology
Impact Factor
41.9
Quartile
Q1
Open Access Type
Hybrid
ISSN
0732-183X
eISSN
1527-7755
Invitation Only
No
Cost Range
A submission fee is mentioned for Case Reports submitted to Journal of Clinical Oncology and not refunded if withdrawn.
Submission Instructions
Journal of Clinical Oncology accepts the following article types. Click on an article type to view submission instructions.
Biology Of Neoplasia
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work and note any prior correspondence with the journal and any prior conference presentation, if applicable.
Abstract
An abstract is required. Abstract must not exceed 275 words. Abstract must be structured. Abstract must use the headings PURPOSE, PATIENTS AND METHODS (or MATERIALS AND METHODS, METHODS, or a similar heading), RESULTS, and CONCLUSION.
Manuscript
Manuscript must not exceed 4000 words, although initial submission may exceed this limit by up to 1000 words.
References
References are limited to 150. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Figures and tables are limited to 6 combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript instead of uploaded separately. Figure legends must be included in the manuscript file, and tables must be cited in numerical order using Arabic numerals.
Original Reports
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work, note any similar work previously reported by the authors, disclose any prior correspondence with the journal, and be addressed to the Editor-in-Chief.
Abstract
A structured abstract is required. Abstract must be 275 words. Abstract must be structured. Abstract must use the headings PURPOSE, PATIENTS AND METHODS or a similar methods heading, RESULTS, and CONCLUSION.
Manuscript
Manuscript must not exceed 3000 words, although initial submission may exceed this limit by up to 1000 words. Manuscript must include a Context Summary following the title page at revision with Key objective, Knowledge generated, and Relevance sections. At revision, the manuscript must include a Context Summary of fewer than 100 words in which Key objective is a single question defining the content and novelty, Knowledge generated consists of two short result sentences without conclusions or interpretation, and Relevance explains clinical application.
References
References must be numbered in the order in which they are cited in the text.
Figures & Tables
Original Reports are limited to 6 figures and tables combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript instead of uploaded separately. Figure legends must be included in the manuscript file, and extended patient demographic data should be presented in a table rather than in the text.
Review Articles
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work, include any similar work previously reported by the authors, and note any prior correspondence with the journal about the manuscript.
Abstract
An abstract is required. Abstract must be 275 words. Systematic reviews, consensus guidelines, and meta-analyses must use a structured abstract, while other Review Articles must use an unstructured abstract. Structured abstracts must use the headings PURPOSE, PATIENTS AND METHODS, RESULTS, and CONCLUSION, with DESIGN permitted instead of PATIENTS AND METHODS for Review Articles.
Manuscript
Manuscript must not exceed 4000 words, although initial submission may exceed this limit by no more than 1,000 words. Review Articles should be disease-focused, examine new data in the field, and describe applications to practice. Review Articles may include one optional graphical abstract at revision, submitted separately, with text under 100 words and 1 to 3 figures.
References
References are limited to 150. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Review Articles are limited to 6 figures and tables combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript rather than uploaded separately if included there. Figure legends must be included in the manuscript file, and table pieces such as Table 1a and 1b are not allowed.
Brief Reports
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work and note any prior correspondence with the journal and any prior conference presentation, if applicable.
Abstract
A structured abstract is required. Abstract must be 275 words. Abstract must be structured. Abstract must use the headings PURPOSE, PATIENTS AND METHODS (or MATERIALS AND METHODS, METHODS, or a similar heading), RESULTS, and CONCLUSION.
Manuscript
Manuscript must not exceed 1500 words, although initial submission may exceed this limit by no more than 1,000 words.
References
References must be numbered in the order in which they are cited in the text.
Figures & Tables
Brief Reports are limited to 3 figures and tables combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript file rather than uploaded separately. Figure legends must be included in the manuscript file, and tables must be cited in the order in which they appear in the text using Arabic numerals.
Case Reports
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work and note any prior correspondence with the journal.
Abstract
Abstract is not required for Case Reports.
Manuscript
Case Reports must not exceed 1500 words, although initial submission may exceed this limit by no more than 1000 words. Case Reports should provide a brief overview of the case and a concise literature review. Case Reports must be supported by data, should provide access to primary data, and should include clear evidence of exceptional response or resistance, a proposed mechanism linking genomic features to response or resistance to targeted therapy, and the variant, platform, and targeted therapy used.
References
Case Reports are limited to 20 references. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Case Reports are limited to 3 figures and tables combined. If figures are included within the manuscript, they do not need to be uploaded separately, and tables must be placed at the end of the manuscript. Figure legends must be included in the manuscript file, and tables must be cited in the order in which they appear in the text using Arabic numerals.
Clinical Trial Updates
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work, note any similar previously reported work and any prior correspondence with the journal, and be addressed to the Editor-in-Chief.
Abstract
An abstract is required. Abstract must be 200 words. Abstract must be unstructured.
Manuscript
Manuscript must not exceed 1200 words, although initial submission may exceed this limit by no more than 1,000 words. Clinical Trial Updates should include a brief description of the trial and a short summary of previous findings to provide context. Updates to randomized phase II and all phase III trials must include a redacted study protocol.
References
References must be numbered in the order in which they are cited in the text.
Figures & Tables
Clinical Trial Updates are limited to 3 figures and tables combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript rather than uploaded separately. Table 1 must include information regarding the patient population, even if repeated from the original publication.
Correspondence
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work, include any similar work previously reported by the authors, and note any prior correspondence with the journal about the manuscript.
Abstract
Abstract requirements are not specified.
Manuscript
Correspondence must not exceed 750 words. Correspondence responding to a JCO article must include the reference to that article and use an original title that differs from the article. Authors should not use artificial intelligence or large language models to generate Correspondence.
References
Correspondence is limited to 10 references. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript file rather than uploaded separately. Figure legends must be included in the manuscript file.
Special Articles
Cover Letter
A cover letter is required. Cover letter must describe the significance and uniqueness of the work, include any similar work previously reported by the authors, note any prior correspondence with the journal, and disclose prior conference presentations if applicable.
Abstract
An abstract is required. Abstract must not exceed 275 words. Abstract must be structured. Abstract must use the headings PURPOSE, PATIENTS AND METHODS (or MATERIALS AND METHODS, METHODS, or a similar heading), RESULTS, and CONCLUSION.
Manuscript
Manuscript must not exceed 4000 words, although initial submission may exceed this limit by no more than 1,000 words. Special Articles should explicitly state the methods used to select committee membership, clearly describe deliberation processes, and explicitly state funding sources.
References
References must be numbered in the order in which they are cited in the text.
Figures & Tables
Special Articles are limited to 6 figures and tables combined. Tables must be placed at the end of the manuscript, and figures may be embedded in the manuscript file rather than uploaded separately if included there. Figure legends must be included in the manuscript file, and tables must be cited in the order in which they appear in the text using Arabic numerals.
Recent Publications
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making
Abdul-Hamid Bazarbachi, Suzanne Lentzsch, Thierry Facon, Jean-Luc Harousseau, Mohamad Mohty
10.1200/jco-26-00545
View Publication
LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma
Sravya Tumuluru, Alan Cooper, Yanwen Jiang, Connie Lee Batlevi, Will Harris, Gilles Salles, Marek Trneny, Georg Lenz, Franck Morschhauser, Fabrice Jardin, Sandhya Balasubramanian, Matthew Sugidono, Alex F. Herrera, Justin Kline, James K. Godfrey
10.1200/jco-26-00451
View Publication
Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743
Arnaud Scherpereel, Paul Baas, Anna K. Nowak, Anne S. Tsao, Nobukazu Fujimoto, Solange Peters, Aaron S. Mansfield, Sanjay Popat, Yolanda Bautista Aragon, Toby Talbot, Francesco Grossi, Dariusz Kowalski, Muhammet A. Kaplan, Andrés Felipe Cardona, Raheela Soomro, Nan Hu, Adam Lee, Virginia Ip, Yu-Han Hung, Gérard Zalcman
10.1200/jco-26-02181
View Publication
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
Sam O. Kleeman, Vered Stearns
10.1200/jco-26-01423
View Publication
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial
Ajay Subramanian, Serey C.L. Nouth, Neda Nemat-Gorgani, Shaghayegh Soudi, Karla V. Ballman, Rachel S. Heise, Claire Johns, Timothy J. Sears, Siyer Roohani, Reinhardt Krcek, Angela M. Hong, Kent J. Weinhold, Matt van de Rijn, Brian E. Brigman, Richard F. Riedel, Yvonne M. Mowery, David G. Kirsch, Everett J. Moding
10.1200/jco-26-00769
View Publication
Frequently asked questions
How long does it take to publish?
Published three times per month — a total of 36 issues per year.
Reformat to Journal of Clinical Oncology using Livewrite PremiumIs a cover letter required?
A cover letter is required as part of the required information for submission under the format-free EZSubmit policy.
Reformat to Journal of Clinical Oncology using Livewrite PremiumWhat are the publication costs?
Journal of Clinical Oncology charges an $80 USD submission fee for Original Reports.
Reformat to Journal of Clinical Oncology using Livewrite PremiumResearch Topics
Lung Cancer Treatments and Mutations
Cancer Treatment and Pharmacology
Colorectal Cancer Treatments and Studies
Cancer Genomics and Diagnostics
Cancer Immunotherapy and Biomarkers
Gastric Cancer Management and Outcomes
Prostate Cancer Treatment and Research
Lung Cancer Research Studies
Breast Cancer Treatment Studies
Economic and Financial Impacts of Cancer
Lymphoma Diagnosis and Treatment
Cancer Diagnosis and Treatment
Pancreatic and Hepatic Oncology Research
HER2/EGFR in Cancer Research
Radiomics and Machine Learning in Medical Imaging
Multiple and Secondary Primary Cancers
Renal cell carcinoma treatment
Advanced Breast Cancer Therapies
Bladder and Urothelial Cancer Treatments
Chronic Lymphocytic Leukemia Research
Hepatocellular Carcinoma Treatment and Prognosis
Lung Cancer Diagnosis and Treatment
Radiopharmaceutical Chemistry and Applications
Cholangiocarcinoma and Gallbladder Cancer Studies
Sarcoma Diagnosis and Treatment